3-methoxybenzamide has been researched along with pc190723 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiwale, ST; Baker, PJ; Barynin, VV; Bennett, JM; Brown, DR; Chauhan, PK; Collins, I; Czaplewski, LG; Errington, J; Galbraith, G; Haydon, DJ; Heal, JR; Rice, DW; Sedelnikova, SE; Sheridan, JM; Srivastava, A; Stokes, NR; Taneja, A; Ure, R | 1 |
| Hu, Z; Ma, X; Xiang, G; Zhang, S; Zhou, W | 1 |
2 other study(ies) available for 3-methoxybenzamide and pc190723
| Article | Year |
|---|---|
An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Binding Sites; Cell Division; Crystallography, X-Ray; Cytoskeletal Proteins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ligands; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tubulin | 2008 |
Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Benzamides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Mycobacterium smegmatis; Pyridines; Staphylococcus aureus; Thiazoles | 2017 |